SANTA ROSA, Calif.,
Aug. 1, 2020 /PRNewswire-PRWeb/ --
Eli Korer, UCG's Chief Legal
Officer, will join a webinar panel of industry experts Wednesday to
discuss the future of cannabis and strategies necessary for success
in a reality altered by COVID-19.
The ABA webinar, called "COVID-19 Impact on Cannabis: Industry
Insights and Expectations," will be held at 1pm EST on August
5th. It is open to the public with a registration fee of
$199 – learn more. Topics include
Distressed Asset Markets, Maneuvering & Maximizing Value, Cash
Crunch in the Cannabis Industry and COVID-19 Impacts on
Legalization Efforts.
"This is a chance to get insider information from industry
experts that could prove invaluable," Korer said. "Anybody
interested in cannabis and how this industry is affected by market
forces and the pandemic should be listening to this webinar – it is
an incredible opportunity for lawyers, investors and cannabis
industry professionals who are either already working in cannabis
or who want to get into the industry."
Other panel members include Jim
Boland, Senior Counsel for Cresco Labs (Chicago, IL), Daniel
Garfield, Founder at McAllister Garfield, P.C. (Denver, CO), with moderator Karen L. Hart, Partner at Bell Nunnally
(Dallas, TX).
The cannabis industry has been affected in significant ways due
to COVID-19, including that cannabis was deemed an "essential
business" in many states and jurisdictions. But Korer said that
despite this, the industry has been radically affected by
challenges from COVID-19 from both a legal and business
perspective. "Not only have state legalization efforts been
impacted, but the cannabis license approval process in many legal
states has stalled, subjecting business participants to delays,
creating financial, operating and other problems."
He compared the current state of affairs to the Great Depression
or Prohibition in that while there is widescale challenge, many
businesses will be able to pull through and be successful with the
right knowledge and tools.
Prior to joining UCG, Korer practiced law at an AM Law 100 law
firm as a member of the corporate department where he represented
public and private companies, nationally and internationally.
UCG owns and operates the award-winning brand Dabstract, a
connoisseur recreational brand that is available throughout the
state of Washington and is
currently expanding to four additional states. UCG is also an
expert in the fields of laboratory design, equipment specification,
hydrocarbon and ethanol extraction, and product formulation.
While the effects of COVID-19 will be a focus of the webinar,
the panel of experts will also go in-depth on general legal topics
relating to the cannabis industry. "Cannabis is undergoing a rapid
market consolidation," Korer said, "which means that cannabis
companies need to prepare themselves for M&A activity. This
panel will provide insight on how to best operate in this new and
energetic environment, as well as how to raise capital, structure
commercial deals and company governance in a way that reduces risk,
and strategically pivot during this time to maximize value."
To register for the webinar, visit
https://www.americanbar.org/events-cle/mtg/web/402615248/
About UCG:
UCG Inc. (UCG) is a cannabis brand and manufacturing intellectual
property licensing company that also specializes in design and
installation services for cannabis extraction facilities,
manufacturing process training, and product formulation. UCG serves
clients in multiple states. UCG designed and currently operates the
largest cannabis processing laboratory in the State of Washington. Dabstract, a premier
brand of recreational cannabis extracts, is a wholly-owned
subsidiary of UCG.
SOURCE Union Cannabis Group